Organization · Venture Capital
Engage Venture Partners
Engage Venture Partners is a Minneapolis-based venture capital firm focused on early-stage investments in medtech companies. They utilize a unique model of co-investing through Special Purpose Vehicles (SPVs) alongside an accredited Investor Network.
Overview
What Engage Venture Partners does
What Engage Venture Partners is
Engage Venture Partners is a Minneapolis-based venture capital firm focused on early-stage investments in medtech companies. They utilize a unique model of co-investing through Special Purpose Vehicles (SPVs) alongside an accredited Investor Network.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- May 2, 2026
Official channels
Find Engage Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Engage Venture Partners as a funder
Investment thesis
Engage Venture Partners invests in early-stage healthcare companies that meet a clear unmet clinical need and can support a venture-scale medtech outcome.
Focus narrative
Engage Venture Partners primarily invests in medical devices, digital health, healthcare IT, and healthcare SaaS. The firm targets companies that have achieved early R&D and MVP milestones, possess a clear regulatory and commercialization pathway, and are raising Seed through Series B capital. Engage's investment strategy is designed to support companies that can demonstrate a significant addressable market and defensible intellectual property.
Value beyond capital
Engage Venture Partners provides value to its portfolio companies by offering access to a network of accredited investors through its SPV model, facilitating streamlined fundraising processes. The firm emphasizes thorough due diligence in clinical, regulatory, and engineering aspects, ensuring that portfolio companies are well-prepared for market entry and growth. Engage also supports its companies in navigating the complexities of the healthcare landscape, enhancing their chances of success.
Terms and economics
- Typical check
- $500,000–$1,500,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Bridge · Series C
- Sectors
- Medical Devices · Digital Health
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Pleural Dynamics: Developing solutions for chronic, recurrent fluid collections. Laplace Interventional: Creating a transcatheter treatment for tricuspid regurgitation. Dosentrx: An outpatient medication-management platform. Diatiro: A kidney-transplant preservation device company. Agitated Solutions: An ultrasound contrast/microbubble generator company. Melodi Health: A development-stage soft-tissue device for reconstructive surgery. VOCxi Health: Focused on breath diagnostics for real-time mobile disease identification.
Common questions
What to know about Engage Venture Partners
Upseed classifies Engage Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 2, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.